Trials / Withdrawn
WithdrawnNCT05032079
Subzero and Scorpion Trial
Pilot Study for the Cryoablation of Ductal Carcinoma In Situ: Subzero and Scorpion Trial
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Larkin Community Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective single-institution pilot study examining the feasibility of performing ultrasound-guided cryoablation to completely ablate breast ductal carcinoma in situ (DCIS). The study is designed such that patients meeting selection criteria will undergo cryoablation followed by surgical resection. The pathology of the surgical specimen will be used to determine the rate of complete tumor ablation. Standard adjuvant therapies otherwise remained unchanged.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | cryoablation | single probe ultrasound guided cryoablation |
Timeline
- Start date
- 2020-11-16
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
- First posted
- 2021-09-02
- Last updated
- 2023-10-16
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05032079. Inclusion in this directory is not an endorsement.